RxDoctor Payments Data

Cara Erkut

Psychiatry · Mercer Island, WANPI 1134440266

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,750 of the $13,854 with a category attached, or 84.8%. Genentech, Inc. accounts for 84.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2021 at $11,750 and has fallen 88.5% since, to $1,351 in 2025. Among psychiatry clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,854in general payments, 2019–2025

Across 106 payments — averaging $130.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$12K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$526
  • AbbVie$424
  • Otsuka America Pharmaceutical, Inc.$202
  • Johnson & Johnson$198
  • Neurocrine Biosciences, Inc.$152
  • plus $602 from 12 others

What the payments were for

  • Consulting fees$11,75085%
  • Food & beverage$2,05715%
  • Education$470%

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,854 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.

See all psychiatry providers in Washington →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate16$58

Paid to pharmacies, not to this prescriber.

Other psychiatry in Mercer Island

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →